Additional file 1 of Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study

Additional file 1: Supplemental Methods, Tables, and Figures. Contains the following: Supplemental Methods. Supplemental Table 1. Concentrations of erythrocyte fatty acids (% of total fatty acids) among cases and matched controls, Nurses’ Health Study II. Supplemental Table 2. Median percent positivity and Spearman correlations of breast tumor immune markers by tumor cell compartment, Nurses’ Health Study II. Supplemental Table 4. Characteristics of potentially eligible breast cancer cases by tumor tissue availability, Nurses’ Health Study II. Supplemental Table 5. Multivariable-adjusted odds ratios (95% CI) for associations between tertiles of total erythrocyte fatty acid concentrations and subsequent breast cancer risk, stratified by tumor expression of immuno-inflammatory markers and fatty acid synthase (FAS), using inverse probability weights to account for potential selection bias, Nurses’ Health Study II. Supplemental Table 6. Multivariable-adjusted odds ratios (95% CI) for associations between tertiles of total erythrocyte fatty acid concentrations and subsequent breast cancer risk, stratified by tumor expression of immuno-inflammatory markers and fatty acid synthase (FAS), restricted to premenopausal women at blood collection, Nurses’ Health Study II. Supplemental Fig. 1. Total erythrocyte fatty acid concentrations and tumor expression of immuno-inflammatory markers and fatty acid synthase (FAS) among breast cancer cases, Nurses’ Health Study II.